Skip to main content

MoneyWorks4Me

Nectar Lifesciences informs about outcome of board meeting

28 Nov 2020 Evaluate
Nectar Lifesciences has informed that pursuant to Reserve Bank India had vide its circulars permitted one-time restructuring for the accounts which were standard as on march 01, 2020, the Board of Directors in its meeting held on today have decided to opt for the one-time restructuring of its debt and authorised the officers of the company to discuss and/ or finalize the one-time restructuring plan with the banks/ financial institutions and/ or to sign any agreement, document application or paper as is required to accomplish the said one-time restructuring.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1768.00
Dr. Reddys Labs. 1340.25
Cipla 1382.00
Lupin 1996.55
Zydus Lifesciences 1239.95
View more..